ClinicalTrials.Veeva

Menu

El Faro: Addressing Mental Health Inequities Among Latinx Children With ADHD in Durham

Duke University logo

Duke University

Status

Completed

Conditions

Psychiatric Health
ADHD

Treatments

Behavioral: El Faro Treatment Intervention

Study type

Interventional

Funder types

Other

Identifiers

NCT05928182
Pro00111427

Details and patient eligibility

About

Study team members from El Futuro in Durham, North Carolina have created an intervention called El Faro. El Faro helps Latinx families of children with ADHD understand and cope with the stress and difficulties presented by the disorder. We propose to develop a community-engaged research partnership between El Futuro and the Duke ADHD Program that aims to pilot-test an adapted El Faro treatment.

Enrollment

32 patients

Sex

All

Ages

6 to 12 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Child is between the ages of 6 to 12 years
  • Child has received a previous diagnosis of ADHD in the community based on caregiver report
  • ADHD Rating Scale (parent rating scale of ADHD symptoms) symptom severity score of 24 or higher
  • Child meets DSM-5 criteria for ADHD (any presentation) based on the MINI
  • Generally healthy (i.e., no major medical problems that will interfere with study participation)
  • Caregiver's willingness to keep any current psychiatric medication regimen for child diagnosed with ADHD constant throughout the study duration
  • Caregiver age 18 years and older
  • Caregiver self-identify as Latinx

Exclusion criteria

  • Caregiver's child has previous diagnosis of Autism, Schizophrenia, or Bipolar Disorder in the community per caregiver report or other psychiatric disorder that is primary to ADHD or may interfere with study involvement.
  • Caregiver unable to attend all El Faro sessions
  • Plan to initiate new ADHD treatment for identified child with ADHD during study participation (previously established ADHD treatments are allowable)
  • Other concerns besides ADHD that would interfere with study participation according to the study team.

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

32 participants in 1 patient group

Treatment Participants
Experimental group
Description:
Active treatment group participants
Treatment:
Behavioral: El Faro Treatment Intervention

Trial documents
1

Trial contacts and locations

1

Loading...

Central trial contact

John Mitchell, PhD; Matthew Gibson

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems